Skip to main content
. 2015 Apr 21;112(10):1626–1635. doi: 10.1038/bjc.2015.109

Table 3. Summary of chemotherapy regime response rate.

      Favourable response of those assessed (%)
 
Chemotherapy regime Total Not assessed Complete Partial Poor response of those assessed (%)
All 94 5 53 (60%) 25 (28%) 11 (12%)
Gemcitabine–cisplatin 43 0 29 (67.4%) 10 (23.3%) 4 (9.3%)
Accelerated MVAC 39 3 20 (55.6%) 12 (33.3%) 4 (11.1%)
Gemcitabine–carboplatin 12 2 4 (40%) 3 (30%) 3 (25%)

Abbreviation: MVAC=methotrexate, vinblastine, Adriamycin and cisplatin.